These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 24811211)
1. The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility. He Z; Wang Q; Sun Y; Shen M; Zhu M; Gu M; Wang Y; Duan Y J Biomater Sci Polym Ed; 2014; 25(9):943-64. PubMed ID: 24811211 [TBL] [Abstract][Full Text] [Related]
2. Degradation behavior and biosafety studies of the mPEG-PLGA-PLL copolymer. He Z; Sun Y; Cao J; Duan Y Phys Chem Chem Phys; 2016 Apr; 18(17):11986-99. PubMed ID: 27067001 [TBL] [Abstract][Full Text] [Related]
3. Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles In Vitro and In Vivo. Guo L; Chen B; Liu R; Xia G; Wang Y; Li X; Wei C; Wang X; Jiang H J Nanosci Nanotechnol; 2015 May; 15(5):3710-9. PubMed ID: 26504996 [TBL] [Abstract][Full Text] [Related]
4. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer. Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487 [TBL] [Abstract][Full Text] [Related]
5. Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas. Liu P; Sun Y; Wang Q; Sun Y; Li H; Duan Y Biomaterials; 2014 Jan; 35(2):760-70. PubMed ID: 24148242 [TBL] [Abstract][Full Text] [Related]
6. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Liu P; Yu H; Sun Y; Zhu M; Duan Y Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800 [TBL] [Abstract][Full Text] [Related]
7. Biocompatibility of filomicelles prepared from poly(ethylene glycol)-polylactide diblock copolymers as potential drug carrier. Shen X; Liu X; Li R; Yun P; Li C; Su F; Li S J Biomater Sci Polym Ed; 2017 Oct; 28(15):1677-1694. PubMed ID: 28627288 [TBL] [Abstract][Full Text] [Related]
8. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma. Cai C; Xie Y; Wu L; Chen X; Liu H; Zhou Y; Zou H; Liu D; Zhao Y; Kong X; Liu P Sci Rep; 2017 Apr; 7():46250. PubMed ID: 28387375 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of blood compatibility of surface modification treated poly (D, L-lactic and glycolic acid) with mPEG block copolymer]. Nie Y; Duan Y; Zhang Z Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Apr; 24(2):336-9. PubMed ID: 17591255 [TBL] [Abstract][Full Text] [Related]
10. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541 [TBL] [Abstract][Full Text] [Related]
11. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil. Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486 [TBL] [Abstract][Full Text] [Related]
12. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel. Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of the genotoxicity of a family of novel MeO-PEG-poly(D,L-lactic-co-glycolic acid)-PEG-OMe triblock copolymer and PLGA nanoparticles. He L; Yang L; Zhang ZR; Gong T; Deng L; Gu Z; Sun X Nanotechnology; 2009 Nov; 20(45):455102. PubMed ID: 19822931 [TBL] [Abstract][Full Text] [Related]
15. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of PEAL nanoparticles with ultrasound targeted microbubble destruction mediated siRNA transfection in human MCF-7/S and MCF-7/ADR cells in vitro. Teng Y; Bai M; Sun Y; Wang Q; Li F; Xing J; Du L; Gong T; Duan Y Int J Nanomedicine; 2015; 10():5447-57. PubMed ID: 26346350 [TBL] [Abstract][Full Text] [Related]
17. Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery. Nie Y; Zhang ZR; He B; Gu Z J Biomater Appl; 2012 May; 26(8):893-916. PubMed ID: 21273262 [TBL] [Abstract][Full Text] [Related]
18. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165 [TBL] [Abstract][Full Text] [Related]
19. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Kim SH; Jeong JH; Chun KW; Park TG Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970 [TBL] [Abstract][Full Text] [Related]
20. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer. Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]